查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604648

心律不整市场：依发生部位、心房、测试设备划分 - 全球预测 2025-2030 年

Arrhythmia Market by Site Of Origin Atrial (Atrial Tachycardia, Premature Atrial Contractions, Sinus Bradycardia), Test Equipment (Electrocardiogram, Holter Monitor) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年心律不整市场规模为60.1亿美元，预计2024年将达到64.8亿美元，复合年增长率为7.97%，预计2030年将达到102.9亿美元。

心律不整是一种以心率不规则为特征的疾病，由于人口老化和心血管疾病意识的增强，其盛行率不断增加，因此需要进行彻底的市场研究。心律不整相关产品和服务市场包括诊断工具、心律调节器和心臟去颤器等治疗设备以及消融手术。医疗产业需要解决心律不整问题，以降低中风风险并提高生活质量，这对于医疗保健提供者、医院和外科中心至关重要。最近的见解表明，人工智慧主导的诊断和穿戴式监控设备等技术进步是关键的成长要素。这些进步不仅提高了早期检测和干预能力，还满足了消费者对非侵入式健康监测解决方案不断增长的需求。此外，微创手术技术在治疗领域具有潜力，扩大了市场机会。

主要市场统计
基准年[2023] 60.1亿美元
预计年份 [2024] 64.8亿美元
预测年份 [2030] 102.9亿美元
复合年增长率（%） 7.97%

儘管有这些机会，但仍存在一些挑战。先进的治疗和诊断工具的高昂成本令人望而却步，凸显了对具有成本效益的创新的需求。监管障碍和广泛的临床试验要求使市场进入和扩张更加复杂。此外，意识低下，尤其是在新兴市场，可能会阻碍市场渗透。透过专注于整合远端医疗和远端监控解决方案，创新者有潜力提高可近性、降低成本并改变都市区和农村环境的医疗保健。此外，透过基因检测和个人化治疗的个人化医疗是一个有前途的研究前沿。

儘管心律不整市场有望成长，但也并非没有挑战。想要成功的公司必须在创新和承受能力之间取得平衡，同时利用监管环境。当前的市场动态表明，正在转向利用技术进步的更整合、消费者友好的解决方案，从而导致公司改变其业务策略和研究工作来满足这些新需求，这将为协调提供坚实的平台。公司应优先考虑策略伙伴关係和研发投资，以有效利用这些机会。

市场动态：揭示快速发展的心律不整市场的关键市场洞察

供需的动态交互作用正在改变心律不整市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 人群中心律不整的盛行率不断增加以及对心律不整监测设备的需求
    • 灌注射频 (RF) 消融导管装置的趋势
    • 关于心律不整的宣传活动日益增多
  • 市场限制因素
    • 与心律不整治疗和设备相关的高成本
  • 市场机会
    • 心律不整设备的技术进步
    • 积极的研究活动开发新的心律不整治疗方法
  • 市场挑战
    • 动态心电图记录用于心律不整监测的局限性

波特五力：驾驭心律不整市场的策略工具

波特的五力架构是了解心律不整市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心律不整市场的外在影响

外部宏观环境因素在塑造心律不整市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解心律不整市场的竞争状况

对心律不整市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心律不整市场供应商的绩效评估

FPNV定位矩阵是评估心律不整市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製心律不整市场的成功之路

心律不整市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人群中心律不整的盛行率不断增加以及对心律不整监测设备的需求
      • 灌注射频 (RF) 消融导管装置的趋势
      • 心律不整意识宣传活动
    • 抑制因素
      • 与心律不整治疗和设备相关的高成本
    • 机会
      • 心律不整设备的技术进步
      • 大力研究发展新的心律不整治疗方法
    • 任务
      • 动态心电图记录在心律不整监测的局限性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章按心房起源部位分類的心律不整市场

  • 房性心搏过速
  • 心房早搏
  • 心搏过缓心搏过缓
  • 移动心房心律调节器

第七章 心律不整市场（依测试设备）

  • 心电图
  • 心电图监测

第八章美洲心律不整市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区心律不整市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲心律不整市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • ACS Diagnostics
  • AliveCor, Inc.
  • AtriCure Inc.
  • Biotricity
  • BIOTRONIK, Inc.
  • Boston Scientific Corporation
  • CardioFocus, Inc.
  • CathRx Ltd.
  • Fukuda Denshi
  • GE Healthcare
  • GlaxoSmithKline PLC
  • Hill-Rom Holdings, Inc
  • iRhythm Technologies Inc.
  • Koninklijke Philips NV
  • Medi-Lynx Cardiac Monitoring, LLC
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Novartis AG
  • OSI Systems, Inc.
  • Sanofi SA
  • SCHILLER
  • Siemens Healthcare GmbH
  • St. Jude Medical, Inc.
Product Code: MRR-A26E0E5742FF

The Arrhythmia Market was valued at USD 6.01 billion in 2023, expected to reach USD 6.48 billion in 2024, and is projected to grow at a CAGR of 7.97%, to USD 10.29 billion by 2030.

Arrhythmia, a condition characterized by irregular heartbeats, necessitates thorough market research due to its rising prevalence, driven by aging populations and increasing awareness of cardiovascular diseases. The market for arrhythmia-related products and services encompasses diagnostic tools, treatment devices like pacemakers and defibrillators, and ablation procedures. The medical industry's necessity to address arrhythmias lies in reducing stroke risk and improving quality of life, making it essential for healthcare providers, hospitals, and surgical centers. Recent insights indicate that technological advances, such as AI-driven diagnostics and wearable monitoring devices, are key growth influencers. These advancements not only improve early detection and intervention capabilities but also cater to the growing consumer demand for non-intrusive health monitoring solutions. Furthermore, the therapeutic sector sees potential in minimally invasive surgical techniques, expanding opportunities within the market.

KEY MARKET STATISTICS
Base Year [2023] USD 6.01 billion
Estimated Year [2024] USD 6.48 billion
Forecast Year [2030] USD 10.29 billion
CAGR (%) 7.97%

Despite these opportunities, several challenges remain. High costs of advanced treatment and diagnostic tools can be prohibitive, underscoring the need for cost-effective innovations. Regulatory hurdles and the extensive clinical trial requirements further complicate market entry and expansion. Also, limited awareness, especially in developing regions, may hinder market penetration. Innovators can focus on the integration of telemedicine with remote monitoring solutions to increase accessibility and reduce costs, potentially transforming care in both urban and rural settings. Additionally, personalized medicine, aided by genetic testing and individualized treatment, represents a promising research frontier.

The arrhythmia market, though poised for growth, is not without its challenges. Companies aiming for success need to balance innovation with affordability while navigating regulatory landscapes. Current market dynamics suggest a shift towards more integrated, consumer-friendly solutions that leverage technological advancements, thus providing a robust platform for organizations to align their business strategies and research efforts to meet these emerging demands. Firms should prioritize strategic partnerships and R&D investments to harness these opportunities effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Arrhythmia Market

The Arrhythmia Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of arrhythmia among population and need for arrhythmia monitoring devices
    • Trend of irrigated radiofrequency (RF) ablation catheter devices
    • Rising awareness campaigns for arrhythmia
  • Market Restraints
    • High-cost associated with arrhythmia treatment and devices
  • Market Opportunities
    • Technological advancements in arrhythmia devices
    • Robust research activities to develop new arrhythmia treatments
  • Market Challenges
    • Limitation of holter recordings for arrhythmia monitoring

Porter's Five Forces: A Strategic Tool for Navigating the Arrhythmia Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Arrhythmia Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Arrhythmia Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Arrhythmia Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Arrhythmia Market

A detailed market share analysis in the Arrhythmia Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Arrhythmia Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Arrhythmia Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Arrhythmia Market

A strategic analysis of the Arrhythmia Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Arrhythmia Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, AliveCor, Inc., AtriCure Inc., Biotricity, BIOTRONIK, Inc., Boston Scientific Corporation, CardioFocus, Inc., CathRx Ltd., Fukuda Denshi, GE Healthcare, GlaxoSmithKline PLC, Hill-Rom Holdings, Inc, iRhythm Technologies Inc., Koninklijke Philips NV, Medi-Lynx Cardiac Monitoring, LLC, Medtronic PLC, MicroPort Scientific Corporation, Nihon Kohden Corporation, Novartis AG, OSI Systems, Inc., Sanofi S.A., SCHILLER, Siemens Healthcare GmbH, and St. Jude Medical, Inc..

Market Segmentation & Coverage

This research report categorizes the Arrhythmia Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Site Of Origin Atrial, market is studied across Atrial Tachycardia, Premature Atrial Contractions, Sinus Bradycardia, and Wandering Atrial Pacemaker.
  • Based on Test Equipment, market is studied across Electrocardiogram and Holter Monitor.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of arrhythmia among population and need for arrhythmia monitoring devices
      • 5.1.1.2. Trend of irrigated radiofrequency (RF) ablation catheter devices
      • 5.1.1.3. Rising awareness campaigns for arrhythmia
    • 5.1.2. Restraints
      • 5.1.2.1. High-cost associated with arrhythmia treatment and devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in arrhythmia devices
      • 5.1.3.2. Robust research activities to develop new arrhythmia treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Limitation of holter recordings for arrhythmia monitoring
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Arrhythmia Market, by Site Of Origin Atrial

  • 6.1. Introduction
  • 6.2. Atrial Tachycardia
  • 6.3. Premature Atrial Contractions
  • 6.4. Sinus Bradycardia
  • 6.5. Wandering Atrial Pacemaker

7. Arrhythmia Market, by Test Equipment

  • 7.1. Introduction
  • 7.2. Electrocardiogram
  • 7.3. Holter Monitor

8. Americas Arrhythmia Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Arrhythmia Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Arrhythmia Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACS Diagnostics
  • 3. AliveCor, Inc.
  • 4. AtriCure Inc.
  • 5. Biotricity
  • 6. BIOTRONIK, Inc.
  • 7. Boston Scientific Corporation
  • 8. CardioFocus, Inc.
  • 9. CathRx Ltd.
  • 10. Fukuda Denshi
  • 11. GE Healthcare
  • 12. GlaxoSmithKline PLC
  • 13. Hill-Rom Holdings, Inc
  • 14. iRhythm Technologies Inc.
  • 15. Koninklijke Philips NV
  • 16. Medi-Lynx Cardiac Monitoring, LLC
  • 17. Medtronic PLC
  • 18. MicroPort Scientific Corporation
  • 19. Nihon Kohden Corporation
  • 20. Novartis AG
  • 21. OSI Systems, Inc.
  • 22. Sanofi S.A.
  • 23. SCHILLER
  • 24. Siemens Healthcare GmbH
  • 25. St. Jude Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. ARRHYTHMIA MARKET RESEARCH PROCESS
  • FIGURE 2. ARRHYTHMIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARRHYTHMIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARRHYTHMIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ARRHYTHMIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ARRHYTHMIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ARRHYTHMIA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ARRHYTHMIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARRHYTHMIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARRHYTHMIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARRHYTHMIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARRHYTHMIA MARKET DYNAMICS
  • TABLE 7. GLOBAL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARRHYTHMIA MARKET SIZE, BY ATRIAL TACHYCARDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARRHYTHMIA MARKET SIZE, BY PREMATURE ATRIAL CONTRACTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARRHYTHMIA MARKET SIZE, BY SINUS BRADYCARDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARRHYTHMIA MARKET SIZE, BY WANDERING ATRIAL PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARRHYTHMIA MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARRHYTHMIA MARKET SIZE, BY HOLTER MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ARRHYTHMIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 101. ARRHYTHMIA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. ARRHYTHMIA MARKET, FPNV POSITIONING MATRIX, 2023